
News|Articles|April 5, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of April 5, 2022
Author(s)Sydney Jennings
Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
Advertisement
How many fully vaccinated Americans have received a booster dose?
According to the Centers for Disease Control and Prevention (CDC)  as of today, April 5, 2022, at 4:35 PM, EDT:
45% of fully vaccinated persons in the US  have received a booster dose of COVID-19 vaccine.
What percentage of people across age groups in the US have been fully vaccinated?
• 65.6% of total US population
• 69.8% of US population aged ≥5 years
• 74% of US population aged ≥12 years
• 75.5% of US population aged ≥18 years
• 89.2% of US population aged ≥65 years
How many cases of COVID-19 have been confirmed in the US?
According to the Johns Hopkins COVID-19 interactive map , as of today, April 5, 2022 at 4:20 PM, EDT, there have been:
• 80 174 153  confirmed cases and
• 982 778   deaths
• 982 778 deaths
The 5 states with the highest total confirmed cases are:
1. California: 9 109 754 
2. Texas: 6 746 069 
3. Florida: 5 885 004  
4. New York: 5 008 016  
5. Illinois: 3 072 640  
2. Texas: 6 746 069
3. Florida: 5 885 004
4. New York: 5 008 016
5. Illinois: 3 072 640
Deaths: California has the highest number of deaths due to COVID-19 with 89 024 reported fatalities, followed by Texas with 87 473 and Florida with 73 290. 
How many cases of COVID-19 have been confirmed globally?
Globally, there have been 492 900 642 confirmed cases, 6 159 600 deaths, and 10 999 814 029 vaccine doses administered. 
Newsletter
Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.
Advertisement
Advertisement
Advertisement
Trending on Patient Care Online
1
Quiz: Recent Advances in Menopause and Midlife Women’s Health Research
2
EPIC-Norfolk Study Supports Universal Screening for Three Cardiovascular Biomarkers
3
Tezepelumab Achieves Dual Benefit in Severe Asthma, Improving Control with Reduced Steroid Dependence
4

































































































































































































































































































